RT @MedPageEndo: What could be the first specific drug to treat osteogenesis imperfecta - a rare genetic #bone-growth disorder - fared pretty well in a phase II trial despite missing one of its primary endpoints, a researcher said at #ASBMR2021. #EndoTwitter https://t.co/NKS9Ex9QiK
RT @MedPageEndo: What could be the first specific drug to treat osteogenesis imperfecta - a rare genetic #bone-growth disorder - fared pretty well in a phase II trial despite missing one of its primary endpoints, a researcher said at #ASBMR2021. #EndoTwitter https://t.co/NKS9Ex9QiK
— Gaston Ramirez (@GastonR48222321) Oct 26, 2021
from Twitter https://twitter.com/GastonR48222321
October 26, 2021 at 05:23PM
Comentarios
Publicar un comentario